Cerus Corp. (NASDAQ:CERS)’s share price reached a new 52-week high during trading on Thursday . The company traded as high as $6.96 and last traded at $6.95, with a volume of 1,465,911 shares trading hands. The stock had previously closed at $6.70.

A number of equities research analysts recently weighed in on CERS shares. BTIG Research reaffirmed a “buy” rating and issued a $10.00 target price (up from $8.00) on shares of Cerus Corp. in a research note on Friday, April 22nd. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $9.00 target price on shares of Cerus Corp. in a research note on Thursday, July 7th. Robert W. Baird reaffirmed an “outperform” rating and issued a $9.00 target price on shares of Cerus Corp. in a research note on Wednesday, June 22nd. Finally, FBR & Co reaffirmed a “buy” rating on shares of Cerus Corp. in a research note on Monday, July 11th. Two analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Cerus Corp. has an average rating of “Buy” and an average price target of $8.90.

The company has a 50-day moving average of $6.30 and a 200-day moving average of $5.84. The firm’s market cap is $751.64 million.

Cerus Corp. (NASDAQ:CERS) last released its quarterly earnings results on Tuesday, May 3rd. The company reported ($0.17) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.16) by $0.01. The firm had revenue of $7.60 million for the quarter, compared to analysts’ expectations of $8.29 million. During the same period in the prior year, the firm earned ($0.17) earnings per share. The firm’s revenue was down 1.3% on a year-over-year basis. On average, analysts predict that Cerus Corp. will post ($0.65) EPS for the current fiscal year.

Other hedge funds and institutional investors recently made changes to their positions in the company. California State Teachers Retirement System increased its position in shares of Cerus Corp. by 1.8% in the fourth quarter. California State Teachers Retirement System now owns 176,709 shares of the company’s stock worth $1,117,000 after buying an additional 3,126 shares during the period. Rail Splitter Capital Management LLC increased its position in shares of Cerus Corp. by 19.0% in the fourth quarter. Rail Splitter Capital Management LLC now owns 832,722 shares of the company’s stock worth $5,263,000 after buying an additional 132,970 shares during the period. Stephens Inc. AR increased its position in shares of Cerus Corp. by 11.3% in the fourth quarter. Stephens Inc. AR now owns 1,112,665 shares of the company’s stock worth $7,032,000 after buying an additional 113,238 shares during the period. Finally, Wells Fargo & Company MN increased its position in shares of Cerus Corp. by 25.9% in the fourth quarter. Wells Fargo & Company MN now owns 4,901,666 shares of the company’s stock worth $30,979,000 after buying an additional 1,007,430 shares during the period.

Cerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment. The Company’s INTERCEPT Blood System is based on its technology for controlling biological replication, and is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.